Cargando…
Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001677/ https://www.ncbi.nlm.nih.gov/pubmed/32082103 http://dx.doi.org/10.3389/fnins.2019.01344 |
| _version_ | 1783494288134373376 |
|---|---|
| author | Kennedy, Adam D. Pappan, Kirk L. Donti, Taraka Delgado, Mauricio R. Shinawi, Marwan Pearson, Toni S. Lalani, Seema R. Craigen, William J. Sutton, V. Reid Evans, Anne M. Sun, Qin Emrick, Lisa T. Elsea, Sarah H. |
| author_facet | Kennedy, Adam D. Pappan, Kirk L. Donti, Taraka Delgado, Mauricio R. Shinawi, Marwan Pearson, Toni S. Lalani, Seema R. Craigen, William J. Sutton, V. Reid Evans, Anne M. Sun, Qin Emrick, Lisa T. Elsea, Sarah H. |
| author_sort | Kennedy, Adam D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7001677 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70016772020-02-20 Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis Kennedy, Adam D. Pappan, Kirk L. Donti, Taraka Delgado, Mauricio R. Shinawi, Marwan Pearson, Toni S. Lalani, Seema R. Craigen, William J. Sutton, V. Reid Evans, Anne M. Sun, Qin Emrick, Lisa T. Elsea, Sarah H. Front Neurosci Neuroscience Frontiers Media S.A. 2020-01-29 /pmc/articles/PMC7001677/ /pubmed/32082103 http://dx.doi.org/10.3389/fnins.2019.01344 Text en Copyright © 2020 Kennedy, Pappan, Donti, Delgado, Shinawi, Pearson, Lalani, Craigen, Sutton, Evans, Sun, Emrick and Elsea. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Neuroscience Kennedy, Adam D. Pappan, Kirk L. Donti, Taraka Delgado, Mauricio R. Shinawi, Marwan Pearson, Toni S. Lalani, Seema R. Craigen, William J. Sutton, V. Reid Evans, Anne M. Sun, Qin Emrick, Lisa T. Elsea, Sarah H. Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis |
| title | Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis |
| title_full | Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis |
| title_fullStr | Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis |
| title_full_unstemmed | Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis |
| title_short | Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis |
| title_sort | corrigendum: 2-pyrrolidinone and succinimide as clinical screening biomarkers for gaba-transaminase deficiency: anti-seizure medications impact accurate diagnosis |
| topic | Neuroscience |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001677/ https://www.ncbi.nlm.nih.gov/pubmed/32082103 http://dx.doi.org/10.3389/fnins.2019.01344 |
| work_keys_str_mv | AT kennedyadamd corrigendum2pyrrolidinoneandsuccinimideasclinicalscreeningbiomarkersforgabatransaminasedeficiencyantiseizuremedicationsimpactaccuratediagnosis AT pappankirkl corrigendum2pyrrolidinoneandsuccinimideasclinicalscreeningbiomarkersforgabatransaminasedeficiencyantiseizuremedicationsimpactaccuratediagnosis AT dontitaraka corrigendum2pyrrolidinoneandsuccinimideasclinicalscreeningbiomarkersforgabatransaminasedeficiencyantiseizuremedicationsimpactaccuratediagnosis AT delgadomauricior corrigendum2pyrrolidinoneandsuccinimideasclinicalscreeningbiomarkersforgabatransaminasedeficiencyantiseizuremedicationsimpactaccuratediagnosis AT shinawimarwan corrigendum2pyrrolidinoneandsuccinimideasclinicalscreeningbiomarkersforgabatransaminasedeficiencyantiseizuremedicationsimpactaccuratediagnosis AT pearsontonis corrigendum2pyrrolidinoneandsuccinimideasclinicalscreeningbiomarkersforgabatransaminasedeficiencyantiseizuremedicationsimpactaccuratediagnosis AT lalaniseemar corrigendum2pyrrolidinoneandsuccinimideasclinicalscreeningbiomarkersforgabatransaminasedeficiencyantiseizuremedicationsimpactaccuratediagnosis AT craigenwilliamj corrigendum2pyrrolidinoneandsuccinimideasclinicalscreeningbiomarkersforgabatransaminasedeficiencyantiseizuremedicationsimpactaccuratediagnosis AT suttonvreid corrigendum2pyrrolidinoneandsuccinimideasclinicalscreeningbiomarkersforgabatransaminasedeficiencyantiseizuremedicationsimpactaccuratediagnosis AT evansannem corrigendum2pyrrolidinoneandsuccinimideasclinicalscreeningbiomarkersforgabatransaminasedeficiencyantiseizuremedicationsimpactaccuratediagnosis AT sunqin corrigendum2pyrrolidinoneandsuccinimideasclinicalscreeningbiomarkersforgabatransaminasedeficiencyantiseizuremedicationsimpactaccuratediagnosis AT emricklisat corrigendum2pyrrolidinoneandsuccinimideasclinicalscreeningbiomarkersforgabatransaminasedeficiencyantiseizuremedicationsimpactaccuratediagnosis AT elseasarahh corrigendum2pyrrolidinoneandsuccinimideasclinicalscreeningbiomarkersforgabatransaminasedeficiencyantiseizuremedicationsimpactaccuratediagnosis |